5 Things To Know About Trump’s New ‘Public Charge’ Immigration Proposal

A proposed rule from the White House would make it harder for legal immigrants to get green cards if they have received certain kinds of public assistance — including Medicaid, food stamps and housing subsidies. Green cards allow them to live and work permanently in the United States.

Read More

Drug Companies Hiking Prices Despite Trump’s Promise to Lower Them

More drug companies raised their prices in the past year than cut them, according to an analysis by The Associated Press published on Monday.

Read More

Employees Spending More On Medical Services, Less On Drugs

Spending on medical services for people enrolled in employer-sponsored health plans increased 44% between 2007 and 2016, according to researchers from the Health Care Cost Institute (HCCI).

Read More

Rising U.S. Healthcare Costs Could Hit Other Sectors of the Economy

The double whammy of rising healthcare costs and an aging population could cause a ripple of negative impacts across the U.S. economy.

Read More

Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate

Gilead Sciences Inc. will sell cheaper versions of its blockbuster hepatitis C drugs, the original versions of which sparked widespread debate about U.S. pharmaceutical costs when they were introduced at a price of more than $1,000 a pill.

Read More

Drug Industry Tries to Slip $4 Billion Windfall Into Opioid Bill

Drug companies usually get what they want in public-policy battles on Capitol Hill, but a move by the pharmaceutical industry to grab $4 billion from the federal Treasury in a bill that is supposed to address the nation’s deadly opioid epidemic is meeting fierce resistance.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square